Description

3-(4-Methyl-Piperazin-1-Ylmethyl)-Benzoic Acid Hydrochloride is a high-purity pharmaceutical intermediate and building block of significant importance in modern organic synthesis. This compound is valued for its role as a key precursor in the development of active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily needed by research institutions, pharmaceutical manufacturers, and fine chemical companies engaged in drug discovery, process development, and custom synthesis projects.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and oncology research.
• API Synthesis: Used as a key precursor in the multi-step manufacturing of complex Active Pharmaceutical Ingredients (APIs).
• Medicinal Chemistry Research: Employed in structure-activity relationship (SAR) studies and lead optimization for new therapeutic agents.
• Custom Synthesis & Contract Manufacturing: Serves as a starting material or intermediate for custom synthesis projects in fine chemical production.
• Chemical Reference Standard: Can be supplied as a high-purity standard for analytical method development and quality control in pharmaceutical labs.
• Bioconjugation & Probe Development: Potential use in creating chemical probes or conjugates for biochemical and diagnostic applications due to its functional groups.

Basic Information

Product Name	3-(4-Methyl-Piperazin-1-Ylmethyl)-Benzoic Acid Hydrochloride
CAS No.	934020-51-6
Molecular Formula	C14H21ClN2O2
Molecular Weight	284.78 g/mol
Synonyms	Benzoic acid, 3-[(4-methyl-1-piperazinyl)methyl]-, hydrochloride (1:1); 3-[(4-Methylpiperazin-1-yl)methyl]benzoic acid hydrochloride; 3-((4-Methylpiperazin-1-yl)methyl)benzoic acid HCl; 3-(4-Methylpiperazin-1-ylmethyl)benzoic acid hydrochloride; 934020-51-6; 3-(N-Methylpiperazinomethyl)benzoic acid hydrochloride; 3-(4-Methyl-1-piperazinylmethyl)benzoic acid monohydrochloride
EINECS	Contact for details

Quality Control

Our 3-(4-Methyl-Piperazin-1-Ylmethyl)-Benzoic Acid Hydrochloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) with complete batch data are provided to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Water Content (KF)	≤1.0%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm
Related Substances (HPLC)	Total impurities ≤2.0%; Any single impurity ≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.